Vera Therapeutics, Inc. (VERA)
34.19
-0.41
(-1.18%)
USD |
NASDAQ |
Aug 28, 16:00
34.22
+0.03
(+0.09%)
After-Hours: 20:00
Vera Therapeutics EPS Diluted (Quarterly) : -1.524 for June 30, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -1.524 |
| March 31, 2026 | -1.693 |
| December 31, 2025 | -1.395 |
| September 30, 2025 | -1.258 |
| June 30, 2025 | -1.200 |
| March 31, 2025 | -0.8119 |
| December 31, 2024 | -0.7192 |
| September 30, 2024 | -0.8494 |
| June 30, 2024 | -0.6159 |
| March 31, 2024 | -0.5568 |
| December 31, 2023 | -0.5771 |
| September 30, 2023 | -0.4532 |
| June 30, 2023 | -0.4554 |
| Date | Value |
|---|---|
| March 31, 2023 | -0.7983 |
| December 31, 2022 | -1.167 |
| September 30, 2022 | -0.9068 |
| June 30, 2022 | -0.5485 |
| March 31, 2022 | -0.7052 |
| December 31, 2021 | -0.7918 |
| September 30, 2021 | -0.3577 |
| June 30, 2021 | -0.1615 |
| March 31, 2021 | -0.2216 |
| December 31, 2020 | -2.015 |
| September 30, 2020 | -0.2096 |
| June 30, 2020 | -0.1694 |
| March 31, 2020 | -0.1163 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | -1.355 |
| Oncolytics Biotech, Inc. | -0.0788 |
| Sangamo Therapeutics, Inc. | -0.0796 |
| Sarepta Therapeutics, Inc. | -0.0464 |
| Anixa Biosciences, Inc. | -0.0749 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -109.47M |
| Total Expenses (Quarterly) | 109.47M |
| Enterprise Value | 2.036B |
| Earnings Yield | -17.17% |
| Normalized Earnings Yield | -17.17 |